Lactobacillus rhamnosus GG attenuates depression‐like behaviour and cognitive deficits in chronic ethanol exposure mice by down‐regulating systemic inflammatory factors Authors: Xiaoyu Pan, Anqi Guo, Kaiyu Guan, Congcong Chen, Shengnan Xu, Yali Tang, Xi Li, Zhengwei Huang Published: 2024 ABSTRACT AbstractEthanol can directly or indirectly lead to cognitive and mental disorders. The long‐term intake of alcohol can directly affect the distribution of gut microbiota. Lactobacillus rhamnosus GG (LGG) is a natural bacterium isolated from healthy human intestines that has the function of preventing cytokine‐induced cell apoptosis and protecting cell barriers. However, the regulatory effect of LGG on cognitive and mental disorders caused by chronic ethanol exposure (CEE) is still unclear. In this study, we established a CEE mouse model through free alcohol consumption and added LGG or antibiotics in the later stages of the model. Sequencing analysis of the 16S rRNA gene showed that CEE resulted in a decrease in the abundance and diversity of mouse gut microbial communities accompanied by alterations in the relative abundance of multiple enterobacterial genera. The use of LGG and antibiotics alleviated the depression‐like behaviour and cognitive impairment of CEE‐induced mice, reduced expression of inflammatory factors such as interleukin (IL)‐6, IL‐1β and tumour necrosis factor (TNF)‐α in the ileum, serum and brain and increased the expression of synaptophysin (SYN), postsynaptic density protein‐95 (PSD‐95) and brain‐derived neurotrophic factor (BDNF) in the hippocampus. Together, LGG can alleviate depression‐like behaviour caused by CEE in mice while also improving cognitive and memory functions through reducing peripheral and nervous system inflammation factors and balancing gut microbiota.Keywords: chronic ethanol exposure, cognitive impairment, depression‐like behaviour, Lactobacillus rhamnosus GG INTRODUCTION Ethanol, commonly known as alcohol and one of the most widely abused substances in the world, is capable of crossing the blood–brain barrier (BBB) and causing damage to the brain. 1 Ethanol has direct neurotoxicity to the brain, which can induce cognitive impairment, mental disorders and other problems. 2 , 3 Studies have shown that long‐term exposure to ethanol can lead to neuroinflammation, which in turn can cause anxiety or depression‐like behaviours. 4 However, the mechanisms involved in this process are still not fully understood. In recent years, the role of the gut microbiota has been increasingly studied. Gut microbiota can affect the central nervous system (CNS) through multiple pathways and participate in the pathogenesis of neuropsychiatric diseases. 5 , 6 Gut microbiota promotes intestinal and peripheral serotonin production in mice, affecting anxiety, hyperactivity and cognition. 7 Germ‐free mice showed increased locomotor activity and decreased anxiety‐like behaviour but returned to normal after gut microbiota transplantation. 8 , 9 In addition, antibiotic‐treated mice had reduced hippocampal neurogenesis and memory retention. 10 These findings underscore the importance of understanding the role that the gut microbiota may play in communication between the gut and brain. More and more evidence show that ethanol affects the composition of gut microbiota, and with the rise of the brain‐gut axis theory, the association between gut microbiota and ethanol neurotoxicity has attracted more attention. 1 To investigate the intrinsic link between gut microbiota and ethanol neurotoxicity, we used a 14‐week chronic ethanol‐induced mouse model. After 3 weeks of antibiotic and Lactobacillus rhamnosus GG (LGG) administration, body weight, behaviour, inflammatory factors and gut microbiota were evaluated for each group. Associations betweenthese factors were then analysed. RESULTS LGG attenuated depression‐like behaviour and cognitive impairment caused by CEE To investigate the effect of LGG on the behaviour of chronic ethanol exposure (CEE) mice, we subjected male mice to a 14‐week ethanol gradient feeding programme and treated the mice with antibiotics, LGG for 3 weeks from Week 11 (Figure 1A). Throughout the experiment, the mice had free access to food and water. Additionally, the mice exhibited subtle differences in both the amount and preference of ethanol intake (Figure 1B–C). In comparison to the control group, the ethanol group displayed a slower growth rate (Figure 1D). Establishment of a model of chronic ethanol exposure (CEE) mouse. (A) Schematic of drug treatment and behavioural tests procedure (MWM, Morris water maze test; OFT, open field test; EPM, elevated plus maze test; FST, forced swimming test; NOR, novel object recognition test). (B) The intake of different concentrations of ethanol in mice (n = 9). (C) Mouse preference for different concentrations of ethanol (n = 9). (D) Body weight of mice after chronic ethanol dependence modelling and drug treatment (n = 9). Based on the fact that chronic alcohol consumption in human causes mood changes and cognitive abnormalities, CEE mice were similarly subjected to relevant behavioural tests. The group of mice exposed to ethanol exhibited reduced locomotion in the open field test (OFT) (Figure 2A, F = 14.87), fewer times and less frequency of entry into the open arm in the elevated plus maze (Figure 2B, F = 1.633; Figure 2C, F = 6.969), a prolonged duration of immobility in the forced swimming test (FST) (Figure 2D, F = 58.96), a lower discrimination index in the 1‐h novel object recognition test (NOR) (Figure 2E, F = 13.83) and fewer times of crossing the target platform in the Morris water maze probe trial(Figure 2F, F = 4.914) than the control group. Lactobacillus rhamnosus GG (LGG) and antibiotics alleviate depression‐like behaviour and cognitive impairment induced by chronic ethanol exposure (CEE). (A) Locomotion distance of mice under different treatments in open field test (n = 9). (B, C) The number and time of different groups entering the open arm in elevated plus maze test(n = 9). (D) Duration of immobility in forced swim test in different groups of mice (n = 5). (E) Short‐term memory performance of different groups of mice in novel object recognition test (n = 9). (F) The number of times different groups of mice crossed the target platform region in the Morris water maze probe trial (n = 6). Data are expressed as the mean ± standard error of mean (SEM). (E + A represents ethanol + antibiotics; E + L represents ethanol + LGG; NS represents no significance; **p < 0.01, ***p < 0.001, ****p < 0.0001, ethanol compared with control; # p < 0.05, ## p < 0.01, #### p < 0.0001, E + A and E + L compared with ethanol). LGG reduced inflammatory factors in the ileum, serum and nervous system of CEE mice A systematic review shows that patients with alcohol use disorder (AUD) have higher serum concentrations of cytokines such as tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β, IL‐6, IL‐7 and IL‐8 compared with controls. 11 In order to evaluate the changes in inflammatory factors in CEE mice and explore the impact of LGG treatment on the levels of ileum, serum and brain inflammatory factors in mice, we extracted samples from mice in each group. Results indicate that the levels of TNF‐α, IL‐1β and IL‐6 were elevated in the ethanol group, compared with the control group (Figure 3A–C; Figure 3A, serum, F = 105.7; ileum, F = 7.71; Figure 3B, serum, F = 452.6; ileum, F = 25.86; Figure 3C, serum, F = 10.86; ileum, F = 5.767). However, after the administration of LGG and antibiotics, there was a significant decrease in the levels of TNF‐α, IL‐1β and IL‐6, compared with the ethanol group (Figure 3A–C). Lactobacillus rhamnosus GG (LGG) and antibiotics restore inflammation factors in ileum and serum of mice induced by chronic ethanol exposure (CEE). (A–C) The content of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β and IL‐6 in the small intestine and serum of mice in each group (n = 6). Data are expressed as the mean ± standard error of mean (SEM). (E + A: ethanol + antibiotics; E + L: ethanol + LGG; NS: no significance; ****p < 0.0001, ethanol compared with control; ## p < 0.01, ### p < 0.001, #### p < 0.0001, E + A and E + L compared with ethanol). Furthermore, the expressions of TNF‐α, IL‐1β and IL‐6 were augmented in the striatum, amygdala, prefrontal lobe and hippocampus of mice exposed to ethanol. Subsequently, following treatment with either LGG or antibiotics, there was a varying degree of restitution of expression levels of TNF‐α, IL‐1β and IL‐6 in each cerebral region (Figure 4A–C; Figure 4A, striatum, F = 7.737; amygdala, F = 21.34; prefrontal lobe, F = 4.147; hippocampus, F = 7.781; Figure 4B, striatum, F = 44.81; amygdala, F = 6.745; prefrontal lobe, F = 13.49; hippocampus, F = 11.14; Figure 4C, striatum, F = 9.889; amygdala, F = 15.04; prefrontal lobe, F = 26.55; hippocampus, F = 12.93). Lactobacillus rhamnosus GG (LGG) and antibiotics can reduce the rise of inflammatory factors in the nervous system caused by chronic ethanol exposure (CEE). (A–C) The content of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β and IL‐6 in the striatum, amygdala, frontal lobe and hippocampus of mice in each group (n = 6). Data are expressed as the mean ± standard error of mean (SEM). (E + A : ethanol + antibiotics; E + L: ethanol + LGG; NS: no significance; **p < 0.01, ***p < 0.001, ****p < 0.0001, ethanol compared with control; # p < 0.05, ## p < 0.01, ### p < 0.001, #### p < 0.0001, E + A and E + L compared with ethanol). Disturbed intestinal flora with reduced lactobacilli in CEE mice 16s RNA gene sequencing was used to study the changes in abundance of intestinal microbiota in CEE mice before and after treatment. A graph of the top 30 richest mouse microbiota (Figure 5A) and a heat map of some differential microbiota (Figure 5B) revealed the differences between the intestinal bacterial genera in each group. Compared with the control group, mice in the ethanol group had a decreased abundance of Lactobacillus, while mice in the LGG group had an increased abundance of Lactobacillus. At the same time, it is accompanied by the recovery or increase of abundance of Escherichia‐Shigella, Streptococcus, Lachnospiraceae unclassified, Anaerotruncus, Eubacterium xylanophilum group, Enterorhabdus, Erysipelotrichaceae unclassified, Ruminococcaceae UCG‐013, GCA‐900066225; in contrast, the abundance of Akkermansia, Ruminococcaceae UCG‐004, Barnesiella, Prevotellaceae UCG‐001 and other bacterial genera has recovered or decreased. Chronic ethanol exposure (CEE) mice exhibit disruption of gut microbiota. (A) Genus distribution of gut microbiota in mice exposed to CEE. (B) Heat map of intestinal microbiota abundance in each group. (C) Principal component analysis (PCA) plots show significant changes in gut microbiota after CEE administration. (D–H) The gut microbiota of mice induced by CEE exhibits a decrease in community richness and diversity (n = 3). Data are expressed as the mean ± standard error of mean (SEM). (E + A: ethanol + antibiotics; E + L: ethanol + Lactobacillus rhamnosus GG [LGG]; NS: no significance; **p < 0.01, ethanol compared with control; # p < 0.05, E + A and E + L compared with ethanol). The results of principal component analysis (PCA) of the bacterial flora (Figure 5C) showed the inter‐group differences in each group. Alpha diversity statistics demonstrate that each group of sample libraries covers a wide range and the detection results are reliable (Figure 5D, F = 1.428). In addition, compared with the control group, the abundance and diversity of intestinal microbiota in the remaining three groups of mice decreased. Due to the broad‐spectrum bactericidal effect of mixed antibiotics, the overall abundance of the antibiotic group decreased the most (Figure 5E–H; Figure 5E, F = 6.281; Figure 5F, F = 6.276; Figure 5G, F = 3.926; Figure 5H, F = 2.339). LGG may attenuate CEE‐induced depressive‐like behaviour and cognitive deficits by protecting nerve cells by reducing the level of inflammatory factors in the nervous system Depression‐like behaviour and cognitive disorders are often accompanied by nervous system inflammation and damage to neurocytes. 12 Yue‐Ming Zhang et al. found that lipopolysaccharide (LPS)‐treated mice increased IL‐1β, IL‐6 and TNF‐α and decreased BDNF, postsynaptic density protein‐95 (PSD‐95) and synaptophysin (SYN) and exhibited anxiety‐depressive‐like behaviour and cognitive impairment. 13 Meanwhile, the hippocampus, a crucial component of the nervous system, causes mice to display anxiety‐ and depression‐like behaviours and develop cognitive deficits when damaged. 14 Compared with the control group, there was a decrease in the expression of synapse‐associated SYN, PSD‐95 and BDNF in the hippocampus of ethanol group. However, following treatment with antibiotics and LGG, expression levels of all three proteins displayed an increase (Figure 6A–C; Figure 6A, F = 9.364; Figure 6B, F = 12.66; Figure 6C, F = 38.24). The above results indicates that LGG can reduce systemic inflammation, protect the nervous system and alleviate depression‐like behaviour and cognitive dysfunction caused by CEE. Lactobacillus rhamnosus GG (LGG) and antibiotics alleviate the decreased expression of neural‐related proteins in the hippocampus of mice induced by chronic ethanol exposure (CEE). (A, B) Representative Western blot and quantification of synaptic proteins in the hippocampus. (C) Representative Western blot and quantification of brain‐derived neurotrophic factor (BDNF) in the hippocampus. Data are expressed as the mean ± standard error of mean (SEM) (n = 3). (E + A: ethanol + antibiotics; E + L: ethanol + LGG; *p < 0.05, **p < 0.01, ****p < 0.0001, ethanol compared with control; # p < 0.05, ## p < 0.01, E + A and E + L compared with ethanol). DISCUSSION CEE is associated with an increased risk of anxiety 15 and depression disorder. 3 , 16 Mice induced by CEE exhibited a decrease in their ability to remember spatial locations as well as their capacity to acquire new memories. 12 50%–75% of those who have abstained from ethanol experience some forms of cognitive or memory impairment. 17 , 18 In our study, the concentration of ethanol provided for free drinking in mice gradually increased. After 14 weeks, the mice exhibited anxiety and depression‐like behaviour with cognitive impairment at the end of CEE modelling. An excessive or prolonged inflammatory response, caused by sustained heavy ethanol use, can be detrimental to the host and has been associated with psychiatric and physical disorders development. 19 Ethanol consumption is found to disrupt immune signalling and promote neuroinflammation by indirectly triggering systemic production of proinflammatory cytokines and directly stimulating the release of inflammatory molecules. 20 , 21 Proinflammatory molecules in the brain can significantly affect neural circuit performance and neuronal plasticity. 22 Studies suggest that the ingestion of probiotics such as Bifidobacteria or Lactobacilli may have positive effects on anxiety and depressive‐like behaviours in pathological conditions 23 and in healthy animals. 24 , 25 Similarly, antibiotic treatments have been shown to affect mice behaviour in multiple ways, indicating that bacteria may be influencing neurological and behavioural outcomes. 26 , 27 , 28 Multiple diagnostic modalities have provided evidence that ethanol consumption can have an effect on neuroimmune signalling in human brain. 29 In the present study, administration of antibiotics reduced the number and abundance of intestinal flora and significantly decreased the levels of inflammatory factors in serum, ileum and nervous system, depression‐like behaviours as well as cognitive deficits in CEE mice. This suggests that the specific gut flora composition of CEE mice may be responsible for elevated inflammatory factors and behavioural changes. Probiotic bacteria provides our body with necessary substances that can prevent inflammation and associated illnesses. 6 Previous research has examined whether reducing the number of bacteria in gut can suppress ethanol‐induced inflammation of CNS and gastrointestinal tract. 30 A meta‐analysis of six studies on the use of probiotics with antidepressant treatments in people with major depressive disorder (MDD) indicates a positive effect of the combination. 31 , 32 Research on LGG has revealed a wealth of data that suggests it is effective in promoting human health. This probiotic has a multitude of functions that affect various bodily systems, such as digestion, respiration, circulation, immunity, movement and nerves. 33 LGG supplementation was shown to strengthen the integrity of the BBB, increase the expression of brain‐derived neurotrophic factor (BDNF) and glial cell line‐derived neurotrophic factor (GDNF) and provide neuroprotection against Parkinson's disease (PD). 34 Early life colonization with LGG could protect the intestinal barrier of offspring and modulate the gut–brain axis, resulting in reduced anxiety‐like behaviour in adulthood. 35 LGG‐derived extracellular vehicles (EVs) have been shown to modulate gut microbiota and reduce inflammation in mice with dextran sulphate sodium (DSS)‐induced colitis. 36 Our experimental results indicate that, similar to the short‐term use of antibiotics, LGG also reduces systemic inflammation and neuroinflammation in CEE mice and alleviates depressive behaviour and cognitive impairment in mice. But the use of combined antibiotics kills the vast majority of bacteria in intestine, which directly affects digestion and absorption of various substances. Previous report suggest that certain combinations of antimicrobial agents may induce depression‐like behaviour and alter depression‐related biomarkers in mice. 37 Compared with antibiotics that are only suitable for short‐term use and may cause unknown side effects, LGG has the advantages oflong term usage with minimal intestinal damage and systemic side effects. Additionally, LGG has the capability to maintain various homeostatic processes in the body. Chronic and excessive ethanol consumption is often associated with cognitive impairment, with a reduction in white matter (WM), axonal loss and demyelination in brain, such as hippocampus and frontal lobe. 38 , 39 , 40 The expression levels of BDNF, PSD‐95 and synapsin‐1 in the hippocampus is closely related to mouse behaviour and cognition. 41 , 42 Inflammation suppression and hippocampal BDNF increase can be used for evaluating improved brain function. PSD‐95 and synapsin‐1, as synaptic‐specific proteins, are closely related to synaptic function. 90‐ and 180‐day ethanol exposure can cause neuronal degeneration in the mouse hippocampus, accompanied by a decrease in BDNF expression and an increase in IL‐6 and IL‐1β. 43 Ethanol intake can hamper learning and memory by interfering with NMDA‐type glutamate receptor‐dependent synaptic plasticity (long‐term depression [LTD] and long‐term potentiation [LTP]) in the hippocampus. 14 Repeated episodes of binge‐like ethanol drinking change the pattern of ethanol consumption and reduce GABAergic transmission in the striatum. 44 Chronic intermittent ethanol (CIE) exposure can disturb the balance between glutamate and gamma‐aminobutyric acid (GABA) neurotransmission, leading to an increased excitability of pyramidal neurons in the basolateral amygdala (BLA) and the manifestation of anxiety during withdrawal. 45 In this study, LGG and antibiotics were observed to reduce the inflammation factors of the striatum, amygdala, frontal lobe and hippocampus in CEE mice, as well as increase the content of PSD‐95, SYN and BDNF in the hippocampus. This may explain the reduced depressive‐like behaviour and weakened cognitive impairment in CEE mice observed as a result of LGG treatment. MATERIALS AND METHODS Animal and ethanol administration Male C57BL/6 mice (3‐month‐old) were purchased from the Beijing Vital River Laboratory Animal Technology Co., Ltd. Mice were housed five animals per cage with free access to water and food. The indoor temperature was controlled at 23 ± 2°C, and the relative humidity was 50% ± 10%. Acclimate the mice for 5–7 days before starting a free‐choice ethanol paradigm (ethanol group) or to water only (control group). 46 Mice were housed individually in standard laboratory cages equipped with two tubes, one containing water and the other containing a solution of ethanol (EtOH) for the ethanol group and two filled with tap water for the control group. Two drinking tubes were continuously available to each mouse, and food was available ad libitum. The ethanol group was exposed to progressively increasing concentrations of EtOH. Briefly, the ethanol group was offered 2% EtOH (v/v) for 1 week, then 5% EtOH (v/v) for the next 3 weeks, and 10% EtOH (v/v) for the next 4 weeks; finally, animals had access to 15% EtOH (v/v) for 6 weeks (stabilization period). The position of the bottles is switched daily to avoid any potential side preference. The amount of fluid consumed from each bottle was measured daily and the body weight of each mouse was weighed weekly. All animal experiments were performed in accordance with the animal guidelines of the animal care and the ethical commission of Wenzhou Medical University. Drug treatments Mice in the control group and ethanol group were administrated with an equal volume of water simultaneously as a control for the operation process. LGG treatment 1 To supplement LGG (ATCC 53103), LGG was grown anaerobically in Man Rogosa and Sharpe (MRS) medium at 37°C for 16 h to reach a concentration of 107 CFU/mL of liquid bacteria, which was calculated using the plate count method. The bacterial culture was then centrifuged at 3500 ×g for 10 min, the supernatant discarded and the pellet resuspended for gavage (1010 CFU/mL). The ethanol group was given distilled water or LGG (1 × 1010 CFU/mL) by gavage at a dose of 10 μL/g once a day for three consecutive weeks starting at Week 11. Antibiotics treatment 30 Mice were either treated twice daily with an oral intragastric gavage of distilled water (control group) or a broad‐spectrum antibiotic cocktail (Abx) containing 1 mg/mL ampicillin, 1 mg/mL neomycin, 1 mg/mL metronidazole and 0.5 mg/mL vancomycin (all antibiotics from Sigma‐Aldrich). Gavages began at a dose of 10 uL/g from Week 11 for 3 weeks. Behavioural tests Behavioural tests were conducted successively after 12 weeks of ethanol exposure. And proceed one by one in the order of Morris water maze test (MWM), OFT, elevated plus maze test (EPM), FST and NOR. Behavioural tests are conducted between 8:00 AM and 5:00 PM. Behavioural videos were recorded and analyzed using the DigBehv animal behaviour analysis system (Shanghai Jiliang Software Technology Co., Ltd.). Open field test (OFT) The OFT was carried out as described by the previous study. 47 The OFT consisted of an empty square box (30 × 30 × 30 cm). The mice were placed individually in the square box and allowed to acclimate for 5 min. The DigBehv animal behaviour analysis system was then used to record videos of the mice for the next 10 min and analyze their total movement distance and movement trajectory. After each test, the box was cleaned with 75% ethanol to eliminate odour cues. Novel object recognition tests (NOR) The NOR test was conducted as follows based on previous research 46 , 48 : On Day 1, mice were allowed to move freely in the test box (65 × 65 × 45 cm)for 5 min to familiarize themselves with the test environment. On Day 2, mice were placed into the same test box in the presence of two identical objects (5 cm away from the side wall) for 5 min; after an inter‐trial interval of 1 h was observed, one familiar object was replaced with a novel object. Mice were placed back within the testing area for 5 min. The same procedure was replicated after a 24‐h interval. Record the object exploration time. After each test, the box was cleaned with 75% ethanol to eliminate odour cues. New object recognition index (NOI) = exploration time of new object/(exploration time of new object + exploration time of old object) × 100%. Morris water maze test (MWM) The MWM is a widely used behavioural test to assess spatial learning and memory in rodents. 49 The MWM test protocol takes 1 week and includes three stages: a free‐swimming stage, a training stage and a testing stage. Before each trial, the water temperature is controlled to be around 25°C, and a white dye is added to make the water opaque. On the first day, the free‐swimming stage is conducted, where mice are placed into the pool from the opposite side of the target quadrant (i.e., where the hidden platform is located) and allowed to swim freely for 1 min while their average speed is recorded. The training stage consists of four trials per day for five consecutive days, where black visual cues of different shapes are attached to the walls of the pool and the platform is submerged 1 cm beneath the water surface in the target quadrant. Mice are placed into the water from one of the four start points in a random order, and the time taken to find the platform is recorded. If a mouse fails to find the platform within 1 min, it is placed onto the platform for 10 s. On the 7th day, a testing session is conducted 24 h after the final training session, during which the platform is removed from the water and each mouse is placed into the pool from the opposite side of the target quadrant for one trial only. The number of times the mouse crosses the target quadrant and the time spent exploring the target quadrant are recorded. Elevated plus maze test (EPM) The EPM test was used as previously reported to evaluate the anxiety‐like behaviours of mice. 47 The EPM was tested by a cross‐shaped maze consisting of two open arms (15 × 5 cm), two closed arms (15 × 5 cm) and a central region (5 × 5 cm). The apparatus was elevated 50 cm above the floor. Each mouse was placed in the centre area facing an open arm and allowed to explore for 5 min. The time spent and the number of total entries into (all four claws) in each arm were recorded using the DigBehv animal behaviour analysis system. After each test, the maze was cleaned with 75% ethanol to eliminate odour cues. Forced swimming test (FST) The FST method was based on previously published article with minor modifications. 50 The test device consisted of a transparent cylindrical glass container (10 cm in diameter, depth of 25 cm, water depth of 10 cm) filled with water (25°C). On Day 1, mice were allowed to move freely for 15 min to adapt to the environment and the test was started 24 h later. The test was conducted for 6 min; the first 2 min was an adaptation phase, after which the immobility of the mouse in the water was recorded for 4 min. Enzyme‐linked immunosorbent assay (ELISA) Mice were anaesthetised using isoflurane, and their blood was extracted from the medial canthus. The supernatant was obtained via centrifugation at 14 000 rpm, 4°C for 15 min. The hippocampus, striatum, amygdala and frontal lobe were isolated by severing the mice's heads after perfusion. Additionally, the ileal tissue was extracted from a 1 cm segment of the intestine that was located around 10 cm away from the cecum's end. Grind according to the ratio of 10 mg sample + 100 μL lysis solution (radioimmunoprecipitation assay (RIPA) + protease inhibitor cocktail (PIC) + phenylmethylsulfonyl fluoride (PMSF), 0.1 g/mL), and then let it stand for 2 h. After that, the supernatant was extracted through centrifugation at 14 000 rpm at 4°C for 20 min. The IL‐6, IL‐1β and TNF‐α contents in serum, small intestine, hippocampus, amygdala, striatum and frontal lobe were determined via ELISA kits (Jingmei Bioengineering Co.) following the manufacturer's instructions. Western blot The protein of brain tissue was extracted using lysis buffer (RIPA:PMSF:PIC = 100:1:1) on ice and disrupted for 1.5 h. The lysates were collected and centrifuged at 14 000 rpm for 20 min to obtain the supernatant. Total proteins were quantified using a Bicinchoninic Acid Assay (BCA) protein assay kit. Equal amounts of protein were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) and transferred to polyvinylidene difluoride (PVDF) membranes. After transfer, the proteins were blocked with 5% skim milk for 2 h and then incubated overnight at 4°C with the following primary antibodies: rabbit anti‐BDNF (1:2500, Abcam, ab108319), rabbit anti‐PSD‐95 (1:2000, Abcam, 38135), rabbit anti‐synaptophysin (1:2000, Abcam, ab32127) and rabbit anti‐muscle actin (1:1000, Abcam, ab156302). Then, the membranes were washed and incubated with horseradish peroxidase (HRP)‐conjugated mouse anti‐rabbit IgG (1:2000, Santa Cruz, sc2357) for 1 h. Chemiluminescent signals were detected and analysed using a ChemiDoc XRS system, and the intensity of the bands was analysed using Quantity One software. 16S rRNA gene sequencing The three mice used for 16s rRNA sequencing were selected using the random number method after the behavioural testing was completed. The animals were housed individually for a day, and their faeces were collected separately for testing. Total bacterial DNA from faecal samples after the administration of the mice was extracted using the DE.Z.N.A. ®Stool DNA Kit (Jingmei Bioengineering Co.), and the quality of the DNA was checked by gel electrophoresis and quantified by UV spectrophotometry. The V3–V4 region of the bacterial 16S rRNA gene was amplified by polymerase chain reaction (PCR) (338F: 5′‐ACTCCTACGGGAGGCAGCAG‐3′ and 806R: 5′‐GGACTACHVGGGTWTCTAAT‐3′), which is approximately 470 bp in length. The PCR products were analysed by 2% agarose gel electrophoresis. The PCR products were purified using AMPure XT beads, quantified using Qubit (Invitrogen, USA) and finally sequenced using the Illumina NovaSeq platform. The paired‐end sequences were assigned to the samples based on their unique barcodes, and the library's barcodes and primer sequences were removed. The FLASH software was used to merge the paired end reads. The raw reads were filtered for quality using fqtrim (v0.94) under specific filtering conditions to obtain high‐quality clean tags. Vsearch software (v2.3.4) was used to perform dereplication on the chimeric sequences. DADA2 was used for denoising and to obtain feature tables and feature sequences. Diversity was calculated by normalizing to the same random sequence. The feature abundance was normalized using the SILVA (release 132) classifier based on the relative abundance of each sample. Alpha diversity was used to analyse the complexity of sample species diversity, with two indices, Shannon and Simpson, calculated for all these indices using QIIME2. Beta diversity was calculated using QIIME2. Statistical analysis All data are expressed as the mean ± standard error of mean (SEM). Student's t‐test was used for comparison between two groups, and one‐way ANOVA (analysis of variance) was used for comparison between multiple groups. When the ANOVA showed significant differences, group comparisons between the mean values were performed by the Dunnett's multiple comparisons. A p‐value of <0.05 was considered significant. GraphPad Prism 9.5.1 was used for statistical analysis. AUTHOR CONTRIBUTIONS Conceptualization: Zhengwei Huang and Xi Li. Methodology: Xiaoyu Pan. Software: Kaiyu Guan. Validation: Xiaoyu Pan, Anqi Guo and Congcong Chen. Formal analysis: Xiaoyu Pan and Zhengwei Huang. Data curation: Yali Tang. Writing—original draft preparation: Xiaoyu Pan, Zhengwei Huang, Anqi Guo and Kaiyu Guan. Writing—review and editing: Zhengwei Huang and Xi Li. Visualization: Congcong Chen and Shengnan Xu. Supervision: Xi Li. Project administration: Zhengwei Huang and Xiaoyu Pan. Funding acquisition: Xi Li. All authors have read and agreed to the published version of the manuscript. Pan X, Guo A, Guan K, et al. Lactobacillus rhamnosus GG attenuates depression‐like behaviour and cognitive deficits in chronic ethanol exposure mice by down‐regulating systemic inflammatory factors. Addiction Biology. 2024;29(11):e13445. doi: 10.1111/adb.13445 Funding information This research was funded by the Natural Science Foundation of Zhejiang Province, project numbers Y21H310024 and LY20C120001; Provincial Program in Medicine and Health Sciences and Technology (grant number 2023565514 to K.G.). And the APC was funded by the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Contributor Information Xi Li, Email: xili_ihb@126.com. Zhengwei Huang, Email: huangzhengwei962@foxmail.com. DATA AVAILABILITY STATEMENT All data generated or analysed during this study are included in this published article. REFERENCES Associated Data Data Availability Statement All data generated or analysed during this study are included in this published article.